Tobacco smoking
Tobacco smoking has been studied in 149 papers since 2016: 1 trial and 114 observational studies in people, 1 in animals, 16 reviews; 59 in the past year. The newest paper, Nov 13, 2026: “Risk factors for metabolic syndrome in first episode psychosis”.
Research on it is growing 26% slower than aging research as a whole: 11 papers in the latest year counted
16 new papers in 30 daysSee all 149 papers on tobacco smoking
At a glance
Independent labs found the same change in people. 46 independent labs in 23 countries.
“The mean difference of HbA1c in non-smokers and smokers was 0.43 ± 0.277 and 0.415 ± 0.230, which shows a higher mean difference in non-smokers, which was statistically non-significant.”
3 of its findings point the other way.
- 46 independent labs in 23 countries
- 3 findings against
- Funders: National Institutes of Health and others
- 5 of 74 findings with company ties
- Human trial1
- Humans114
- Animals1
- In silico17
What did studies of tobacco smoking find?
27Studies of tobacco smoking measured 27 outcomes; the most studied are telomere length (4 studies), handgrip strength (2) and walking pace (2).
Telomere length
downin silico2downin humans1no changein humans1OR 0.882
4 studies
Telomere length
downin silico2downin humans1no changein humans1OR 0.882
Tobacco smoking is linked with lower telomere length in humans (-0.041 (-0.054, -0.028) per 2-fold prevalence increase in smoking).
Humansn = 337,318
Tobacco smoking was not clearly linked with telomere length in humans (without lung damage).
Humanswithout lung damageCD4+ and CD8+ T lymphocytesover 30 years
Tobacco smoking decreases telomere length in silico (OR 0.882, 95% CI 0.847-0.918).
In silico
Tobacco smoking decreases telomere length in silico (MR analysis (twofold increase in prevalence of smoking)) (-0.041 [-0.054, -0.028]).
In silicoMR analysis (twofold increase in prevalence of smoking)
Handgrip strength
no changein humans1no changein silico1
2 studies
Handgrip strength
no changein humans1no changein silico1
Tobacco smoking was not clearly linked with handgrip strength in humans (0.074 (-0.055, 0.204) kg).
Humansn = 337,318
Tobacco smoking showed no clear effect on handgrip strength in silico (MR analysis) (0.074 [-0.055, 0.204] kg).
In silicoMR analysis
Walking pace
downin humans1downin silico1
2 studies
Walking pace
downin humans1downin silico1
Tobacco smoking is linked with worse walking pace in humans (-0.047 (-0.054, -0.033)).
Humansn = 337,318
Tobacco smoking impairs walking pace in silico (MR analysis) (-0.047 [-0.054, -0.033]).
In silicoMR analysis
Appendicular lean mass index
downin humans1downin silico1
2 studies
Appendicular lean mass index
downin humans1downin silico1
Tobacco smoking is linked with lower appendicular lean mass index in humans (-0.007 (-0.010, -0.005)).
Humansn = 337,318
Tobacco smoking decreases appendicular lean mass index in silico (MR analysis) (-0.007 [-0.010, -0.005]).
In silicoMR analysis
HbA1c
no changein humans1
1 study
HbA1c
no changein humans1
Tobacco smoking showed no clear effect on HbA1c in humans.
Human trial3 monthsn = 40
Tobacco smoking showed no clear effect on HbA1c in humans (periodontal therapy mean difference comparison between smokers and non-smokers) (0.43 ± 0.277 vs 0.415 ± 0.230).
Human trialperiodontal therapy mean difference comparison between smokers and non-smokersn = 40
Brain volume
downin humans1
1 study
Brain volume
downin humans1
Tobacco smoking decreases brain volume in humans.
Reviewbrain
Inflammation
upin humans1
1 study
Inflammation
upin humans1
Tobacco smoking induces inflammation in humans.
Reviewbrain
GrimAge2
upin humans1
1 study
GrimAge2
upin humans1
Tobacco smoking is linked with higher GrimAge2 in whole blood and isolated immune cell types.
Humansin whole blood and isolated immune cell types
Smoking linked to aging measures in human immune cells
Clinical epigenetics
DunedinPACE
upin humans1
1 study
DunedinPACE
upin humans1
Tobacco smoking is linked with higher DunedinPACE in whole blood and isolated immune cell types.
Humansin whole blood and isolated immune cell types
Smoking linked to aging measures in human immune cells
Clinical epigenetics
DNAmTL
downin humans1
1 study
DNAmTL
downin humans1
Tobacco smoking is linked with lower DNAmTL in humans across six major immune cell types.
Humansacross six major immune cell types
Smoking linked to aging measures in human immune cells
Clinical epigenetics
All 27Fewer
What is tobacco smoking linked with?
48Studies link tobacco smoking with 48 measures, most often cancer incidence (3 studies), oxidative stress and ROS signaling (2) and multimorbidity (2).
Cancer incidence
upin humans3+15% cancer burden attributable to smoking
3 studies
Cancer incidence
upin humans3+15% cancer burden attributable to smoking
Tobacco smoking is associated with cancer incidence in humans (Population-attributable fraction estimates) (26.8% of cancer cases attributable to tobacco smoking).
HumansPopulation-attributable fraction estimates
Tobacco smoking is linked with a higher risk of cancer incidence in humans (Global burden in 2022) (17.2% population attributable fraction).
HumansGlobal burden in 2022
Tobacco smoking is associated with cancer incidence in humans (global estimates) (15.1% of cancer burden attributable to smoking).
Humansglobal estimates2022
Oxidative stress and ROS signaling
upin humans2
2 studies
Oxidative stress and ROS signaling
upin humans2
Tobacco smoking is associated with oxidative stress and ROS signaling in humans (compared with never smokers and other tobacco use categories).
Humanscompared with never smokers and other tobacco use categories
Tobacco smoking is associated with oxidative stress and ROS signaling in humans.
Humansn = 620
Multimorbidity
upin humans2
2 studies
Multimorbidity
upin humans2
Tobacco smoking is associated with multimorbidity in humans (Residents of the Manguinhos slum complex).
HumansResidents of the Manguinhos slum complexfemales
Tobacco smoking is associated with multimorbidity in humans (Women in India) (AOR 1.87, CI 1.65–2.10; population attributable risk 1.2% (p<0.001)).
HumansWomen in Indiafemalesn = 699,686
Frailty
upin humans2HR 1.79
2 studies
Frailty
upin humans2HR 1.79
Tobacco smoking is linked with a higher risk of frailty in humans (people with HIV) (HR: 1.79; 95% confidence interval: 1.54 to 2.08).
Humanspeople with HIVmean 5.3 yearsn = 8,608
Tobacco smoking is associated with frailty in humans (P-value < 0.05).
Humans
Fuchs endothelial corneal dystrophy
downin humans1upin humans1HR 0.92–1.12
1 study
Fuchs endothelial corneal dystrophy
downin humans1upin humans1HR 0.92–1.12
Tobacco smoking is linked with a lower risk of Fuchs endothelial corneal dystrophy in humans (former vs never smokers) (HR = 0.92, CIs: 0.84-1.01).
Humansformer vs never smokersfemales
Tobacco smoking is linked with a higher risk of Fuchs endothelial corneal dystrophy in humans (current vs never smokers) (HR = 1.12, CIs: 0.90-1.38).
Humanscurrent vs never smokersfemales
Metabolic syndrome
upin humans1
1 study
Metabolic syndrome
upin humans1
Tobacco smoking is associated with metabolic syndrome in humans (first-episode psychosis).
Humansfirst-episode psychosis>20 cigarettes daily2 years66% malesn = 456
Parkinson's disease risk
downin humans1
1 study
Parkinson's disease risk
downin humans1
Tobacco smoking is associated with Parkinson's disease risk in humans (32-60% risk reduction in smokers).
Review
FEF25-75%
downin humans1
1 study
FEF25-75%
downin humans1
Tobacco smoking is associated with FEF25-75% in humans (Conventional cigarette smokers compared with controls).
HumansConventional cigarette smokers compared with controlsn = 22
Lung cancer mortality
upin humans1
1 study
Lung cancer mortality
upin humans1
Tobacco smoking is associated with lung cancer mortality in humans (Persons with opioid use disorder).
HumansPersons with opioid use disorderIncreasing smoking frequency
Lung cancer incidence
upin humans1
1 study
Lung cancer incidence
upin humans1
Tobacco smoking is associated with lung cancer incidence in humans (Persons with opioid use disorder).
HumansPersons with opioid use disorderIncreasing smoking frequency
All 48Fewer
What acts on tobacco smoking?
1Studies name covid-19 pandemic as acting on tobacco smoking.
COVID-19 pandemic
upin humans1
1 study
COVID-19 pandemic
upin humans1
COVID-19 pandemic is linked with higher tobacco smoking in humans during the first year of the COVID-19 pandemic (2020) vs prepandemic (2011-2018) (aOR 1.12, 95% CI 1.07, 1.17).
Humansduring the first year of the COVID-19 pandemic (2020) vs prepandemic (2011-2018)n = 44,139
Funding
1 grant since 2024American Heart Association$152K